Sign in
Taking people in United StatesNo phase

Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

Key facts

Who runs it
VA Palo Alto Health Care System
Where
Palo Alto, United StatesSee the site
Trial code
Status
Recruiting
People taking part
40 people, planned
Started
25 Aug 2025
Planned end
1 Jan 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Active Transcranial Magnetic Simulation
  • Sham
Record updated
13 August 2025

Who can take part

Age
25 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Between age 25 and 75
  • Current DSM-5 diagnosis of moderate to severe AUD (≥4 diagnostic symptoms)
  • Able to attend scheduled clinic visits
  • Able to read, understand and voluntarily sign Informed Consent prior to participating in any study-specific procedures or assessments
  • If on a medication regimen, that regimen will be stable for the duration of the study
  • Fluency in English

Who cannot take part

  • Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk
  • Participation in another concurrent intervention based clinical trial
  • Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, metal in the head, metal in the body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/objected in the head and body within 30 cm of the treatment coil
  • General medical condition, disease or neurological disorder that interferes with the assessments or participation
  • Have a mass lesion, cerebral infarct, or other active CNS disease, including an alcohol-related seizure or a seizure disorder. • A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study
  • Taking benzodiazepine or neuroleptic medications, or any medication known to alter seizure threshold
  • unstable chronic illness
  • Current or lifetime history of bipolar disorder or psychosis
  • Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen
  • Severe impediment to vision, hearing and/or hand movement, likely to interfere with the ability to follow study protocols. • Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness)

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 25 and 75 years old?

This trial is currently available in United States.

  • VA Palo Alto Health Care SystemPalo Alto, United StatesContact: Luzille CowlahTaking people

About the trial

What the trial wants to find out

Alcohol Use Disorders are currently positioned as the third leading cause of preventable death in the United States, constituting a humanitarian crisis with substantial financial burden on society and medical facilities. While several pharmacological interventions exist, 60% of individuals who seek these treatments relapse to alcohol within 6 months. These high relapse rates are due in part to elevated brain response to alcohol cues in the environment. This study seeks to evaluate the efficacy of one session of functional Magnetic Resonance Imaging (fMRI) guided transcranial magnetic stimulation (TMS) as a strategy to reduce brain reactivity to alcohol cues.

The 2 groups in the trial

  • Active fMRI-guided TMSTreatment being tested

    Treatment: Active Transcranial Magnetic Simulation

  • Sham fMRI-guided TMSSham treatment, for comparison

    Treatment: Sham

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06415721, who can take part
Record updated
13 August 2025